• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

USPSTF recommends biennial screening mammography in 50 to 74 year-old women

byKenan Celtik, MSandSai Folmsbee
January 11, 2016
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. From a systematic review of the evidence, the U.S. Preventative Services Task Force (USPSTF) recommends screening mammography every other year in women 50 to 74 years old and individualizing the decision to begin mammography in women 40 to 49 years old, with insufficient evidence to make a recommendation for screening in women over 75 years old.

2. The USPSTF found insufficient evidence to make recommendations regarding the use of digital breast tomosynthesis as a primary screening method and for the use of adjunctive imaging (ultrasound, MRI, DBT, etc.) in women identified as having dense breasts.

Evidence Rating Level: 2 (Good)

Study Rundown: The recommendation statements by the United States Preventative Services Task Force (USPSTF) are based on reviews of the current evidence regarding the benefits and harms of preventative health care services. Breast cancer represents the second most common cause of death in women, making adequate screening tests a public health priority. However, screening mammography is not without harm, as the overdiagnosis and subsequent treatment of non-life-threatening breast cancers may result in unnecessary surgery. From this current analysis, the USPSTF recommended screening mammography every other year for women 50 to 74 years old. The decision to begin biennial screening in the fourth decade of life should be individualized to the patient, as this age group was less likely to avoid death and had greater false positive rates, which ultimately lead to greater unnecessary invasive biopsies. Nonetheless, screening in this age group may be beneficial in women with a first-degree relative who had breast cancer. Furthermore, there was insufficient evidence to make a recommendation regarding screening mammography in women over 75 years old. Additionally the USPSTF found insufficient evidence to assess the adequacy of digital breast tomosynthesis (DBT) as a primary screening method or to assess the use of adjunctive imaging (ultrasound, MRI, DBT) in women with dense breasts. Overall, this recommendation may guide primary care providers in deciding when to begin screening mammography in their patients.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: Reduction in mortality from breast cancer after mass screening with mammography

In-Depth [systematic review]: The USPSTF conducted a systematic review of current evidence on the utility of screening mammography in the prevention of breast cancer. The number of breast cancer deaths avoided over 10 years per 10,000 women screened was 4 (95%CI 0-9) for women ages 40-49, 8 (95%CI 2-17) for age 50-59, 21 (95%CI 11-32) for ages 60-69 and 13 (95%CI 0-32) for ages 70-74. The USPSTF recommendations were based on maximizing the number of deaths avoided while also taking into account the number of false positives, breast biopsies and missed cancers. These recommendations apply to women over 40 years without breast cancer or prior high-risk breast masses and no BRCA1/2 mutations or history of chest radiation at a young age. The USPSTF Grade B recommendation suggests biennial screening mammography from age 50 to 74 years because screening in this age group resulted in the greatest reduction in risk of cancer-death. There was a small net benefit found for beginning screening in women age 40 to 49, and therefore the recommendation (Grade C) was to individualize the decision on when to begin screening to each patient. Due to insufficient evidence, the USPSTF could make no recommendations regarding women over 75 years old, digital breast tomosynthesis for primary screening, or the use of adjunctive imaging in women with dense breasts (Grade I). 

RELATED REPORTS

Combination mammography and breast tomosynthesis improves breast cancer screening [Classics Series]

Breast density increases the risk of cancer and hinders mammographic detection [Classics Series]

Breast MRI most sensitive screening modality in high-risk patients [Classics Series]

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: mammographyuspstf
Previous Post

Age and breast cancer risk factors associated with false-positive mammography results

Next Post

Education combined with exercise linked to reduction of low-back pain episodes

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Combination mammography and breast tomosynthesis improves breast cancer screening [Classics Series]

August 16, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Breast density increases the risk of cancer and hinders mammographic detection [Classics Series]

August 11, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Radiology Classics

Breast MRI most sensitive screening modality in high-risk patients [Classics Series]

August 9, 2022
2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Screening with digital breast tomosynthesis vs mammography associated with significantly lower risk of advanced breast cancer among women with extremely dense breasts at high risk of breast cancer

June 16, 2022
Next Post
Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Education combined with exercise linked to reduction of low-back pain episodes

Molecular testing for Clostridium difficile may not predict disease activity

Frozen fecal microbiota transplantation effective for recurrent Clostridium difficile

Urinary mRNA profiling accurately diagnoses rejection in kidney allografts

Chronic kidney disease prognosis calculators remain accurate in non-North American patient populations.

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options